DEUTSCHE BANK AG\
BankPosition in AGIO — Agios Pharmaceuticals, Inc.
CIK 948046
FRANKFURT AM MAIN, 2M
Position in AGIO
as of Mar 31, 2026
· filed May 6, 2026
Position Value
$1,704,490
-$1,640,166 QoQ
Shares Held
50,384
-59.0% QoQ
Ownership
0.085%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in AGIO Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026DEUTSCHE BANK AG\ holds $2,973,536,998 across 248 Biotechnology names. AGIO ranks #109 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
1,537,736 | $686,660,626 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
625,388 | $483,199,777 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
761,464 | $251,945,590 | |
| 4 | INCY |
Incyte Corp
|
1,264,195 | $118,986,027 | |
| 5 | RPRX |
Royalty Pharma plc
|
2,453,303 | $117,684,942 | |
| 6 | ARGX |
Argenx SE
|
139,381 | $101,782,972 | |
| 7 | INSM |
INSMED Inc
|
562,474 | $91,975,745 | |
| 8 | LGND |
Ligand Pharmaceuticals Inc
|
306,111 | $61,115,059 |
All Filings in AGIO
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $1,704,490 | 50,384 | Shares | Defined | 2026-05-06 | |
| 2025-12-31 | $3,344,656 | 122,875 | Shares | Defined | 2026-02-11 | |
| 2025-09-30 | $37,199,102 | 926,734 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $30,651,949 | 921,586 | Shares | Defined | 2025-08-12 | |
| 2025-03-31 | $27,218,820 | 928,970 | Shares | Defined | 2025-05-09 | |
| 2024-12-31 | $30,732,380 | 935,252 | Shares | Defined | 2025-06-30 | |
| 2024-09-30 | $29,750,994 | 669,615 | Shares | Defined | 2025-06-26 | |
| 2024-06-30 | $28,555,616 | 662,236 | Shares | Defined | 2025-06-12 | |
| 2024-03-31 | $19,511,763 | 667,297 | Shares | Defined | 2025-06-02 | |
| 2023-12-31 | $12,945,527 | 581,299 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $14,394,624 | 581,601 | Shares | Defined | 2023-11-24 | |
| 2023-06-30 | $16,368,251 | 577,975 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $13,551,632 | 589,971 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $16,329,670 | 581,541 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $16,464,446 | 582,194 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $12,395,156 | 559,096 | Shares | Defined | 2022-08-11 | |
| 2022-03-31 | $16,326,429 | 560,853 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $18,775,868 | 571,216 | Shares | Defined | 2022-02-16 | |
| 2021-09-30 | $31,032,735 | 672,432 | Shares | Defined | 2021-11-04 | |
| 2021-06-30 | $38,141,352 | 692,095 | Shares | Defined | 2021-08-11 | |
| 2021-03-31 | $36,562,460 | 708,026 | Shares | Defined | 2021-05-13 | |
| 2020-12-31 | $32,349,786 | 746,591 | Shares | Defined | 2021-02-16 | |
| 2020-09-30 | $15,469,650 | 441,990 | Shares | Defined | 2020-11-12 | |
| 2020-06-30 | $26,520,356 | 495,893 | Shares | Defined | 2020-08-13 | |
| 2020-03-31 | $19,754,623 | 556,782 | Shares | Defined | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||